We investigated mechanisms of cell death during hypoxia/reoxygenation of cultured kidney cells. During glucose-free hypoxia, cell ATP levels declined steeply resulting in the translocation of Bax from cytosol to mitochondria. Concurrently, there was cytochrome c release and caspase activation. Cells that leaked cytochrome c underwent apoptosis after reoxygenation. ATP depletion induced by a mitochondrial uncoupler resulted in similar alterations even in the presence of oxygen. Moreover, inclusion of glucose during hypoxia prevented protein translocations and reoxygenation injury by maintaining intracellular ATP. Thus, ATP depletion, rather than hypoxia per se, was the cause of protein translocations. Overexpression of Bcl-2 prevented cytochrome c release and reoxygenation injury without ameliorating ATP depletion or Bax translocation. On the other hand, caspase inhibitors did not prevent protein translocations, but inhibited apoptosis during reoxygenation. Nevertheless, they could not confer long-term viability, since mitochondria had been damaged. Omission of glucose during reoxygenation resulted in continued failure of ATP production, and cell death with necrotic morphology. In contrast, cells expressing Bcl-2 had functional mitochondria and remained viable during reoxygenation even without glucose. Therefore, Bax translocation during hypoxia is a molecular trigger for cell death during reoxygenation. If ATP is available during reoxygenation, apoptosis develops; otherwise, death occurs by necrosis. By preserving mitochondrial integrity, BCL-2 prevents both forms of cell death and ensures cell viability.
Introduction
Mechanisms of cell death resulting from ischemia and reperfusion are poorly understood but are thought to involve both apoptosis and necrosis in several cell types (Kato et al., 1997; Kajstura et al., 1998; Li et al., 1998a; Wiegele et al., 1998; Lieberthal and Levine, 1996; Noda et al., 1998) . Injury during reperfusion is thought to be driven by processes that are related to reoxygenation (McCord, 1985; Cotran et al., 1998) . On the other hand, cells may become damaged during the ischemic period itself, owing to energy declines caused by hypoxia and deprivation of metabolic substrates. These alterations can predispose previously hypoxic cells to undergo accelerated injury during reoxygenation (Cotran et al., 1998) . Recent reports have suggested that hypoxic or ischemic cell death is prevented by anti-apoptotic members of Bcl-2 family (Shimizu et al., 1995; Jacobson and Ra, 1995; Martinou et al., 1994) and by inhibitors of the caspase family of cysteine proteases (Shimizu et al., 1996; Cheng et al., 1998; Yaoita et al., 1998) . However, the relevant death mechanisms remain to be elucidated.
Apoptotic processes set in motion by non-hypoxic stimuli involve at least two discrete mechanisms initiated by two distinct caspases, with downstream activation of common eector caspases which result in cellular disassembly. One mechanism, commonly associated with cytotoxic agents, radiation and growth factor withdrawal, involves the activation of initiator caspase-9 and requires the formation of a ternary complex with cytochrome c released from mitochondria and a cytosolic co-factor Apaf-1 in the presence of ATP or dATP Pan et al., 1998) . Release of apoptogenic factors such as cytochrome c caused by increased mitochondrial permeability is a proximate trigger for this type of apoptosis (Yang et al., 1997; Kluck et al., 1997) . Thus, by inhibiting cytochrome c release, anti-apoptotic members of the Bcl-2 family can abort the death cascade (Yang et al., 1997; Kluck et al., 1997) . Caspase inhibitors have the power to prevent structural damage attributable to downstream enzymatic events, but need not, a priori, preserve mitochondrial integrity and therefore may only delay cell death (McCarthy et al., 1997; Miller et al., 1997; Xiang et al., 1996) .
The other mechanism underlies apoptosis caused by ligation of death receptors, which recruit and proteolytically activate the initiator caspase-8 (Ashkenazi and ) that in turn triggers eector caspases. This death cascade may also be ampli®ed by caspase-8-mediated mitochondrial damage and release of apoptogenic factors (Luo et al., 1998; Li et al., 1998b) . Under these conditions caspase inhibitors oer complete protection against injury. Inhibition of the proximally located trigger caspase-8 not only aborts downstream, eector caspase related death events, but also ensures that caspase-8-mediated mitochondrial damage does not occur (Luo et al., 1998; Li et al., 1998b) .
Mitochondrial damage has long been considered to play a role in hypoxic and ischemic cell death, but the contribution of apoptogenic mechanisms to these ubiquitous pathophysiological processes is poorly de®ned. Caspase inhibitors aord some protection against ischemic injury, but it is not known whether they protect by decreasing in¯ammation, or by retarding hypoxia related death cascades in the parenchymal cells. This is an important consideration for mammalian cells, since they are obligately dependent on mitochondrial function for long-term viability. Therefore, if mitochondrial damage were to be the proximate trigger that activates caspases and thereby initiates hypoxic cell injury, inhibition of caspases might not be expected to protect the involved cells permanently. There are other gaps in our knowledge of hypoxic death mechanisms. Thus, it is currently not known whether apoptosis is triggered by hypoxic death signals independent of the energetic state of the cell, or if ATP depletion is a prerequisite.
Apoptosis may be triggered by pro-apoptotic members of the Bcl-2 family of proteins (Adams and Cory, 1998) . Mitochondrially located Bax led to cell death following Bax transfection or treatment with certain cytotoxic agents (Wolter et al., 1997; Gross et al., 1998) . In both cases, cytochrome c was released from mitochondria, caspases were activated, and these events were inhibited by Bcl-2 (Yang et al., 1997; Kluck et al., 1997) . Whether Bax ®gures in hypoxic/ ischemic insults is unclear.
We have examined the intracellular signals triggered by hypoxic stress which result in cell death during reoxygenation. We show for the ®rst time that hypoxia induces time-dependent translocation of cytosolic Bax to mitochondrial membranes. The ®ndings also establish that ATP depletion, rather than hypoxia per se, is responsible. Translocation of Bax was associated with mitochondrial permeability alterations, release of cyt.c and caspase activation, all of which took place during ATP depletion. These biochemical alterations triggered apoptosis during reoxygenation if glycolytic ATP was available, but led to necrosis if ATP production was compromised due to lack of glycolysis. This indicated the persistence of mitochondrial failure during reoxygenation. Bcl-2 did not inhibit Bax translocation induced by ATP depletion. However, it prevented the release of cyt.c, aborted the activation of death pathways, and promoted cell viability by preserving the mitochondrial integrity required for ATP synthesis. The primacy of mitochondrial failure in this form of cell death was shown further by the eects of caspase inhibitors. Although these agents inhibited caspase-dependent death pathways and preserved cell structure, protection was only temporary because mitochondrial loss of cyt.c and attendant respiratory dysfunction were irreversible.
Results

Caspase-mediated cell death during reoxygenation
After 5 h of glucose-free hypoxia, cultured rat proximal tubule cells (RPTC) were transferred to normoxic full culture medium containing 17.5 mM glucose. Death of about 50% of the cell population resulted within 2 h. As shown in Figure 1a (5H/2R, N/A), the aected cells displayed typical apoptotic morphology with cell shrinkage and membrane blebbing. Additionally, staining with Hoechst 33258 demonstrated chromatin condensation and nuclear fragmentation. Consistent with these morphological observations, DNA breakdown ( Figure 1b , 5H/2R: N/A) and cleavage of nuclear lamin B were also observed ( Figure 1c, lane 3) , as in other apoptotic cell death models (Lazebnik et al., 1995) . These morphological and biochemical features of apoptosis did not occur during hypoxia alone (Figure 1a ± c, 5H) but required reoxygenation (Figure 1a ± c, 5H/2R: N/A). Moreover, VAD (carbobenzoxy-Val-Ala-Asp-fluoromethyl ketone), a broad spectrum inhibitor of caspases, suppressed reoxygenation induced alterations (Figure 1a ± c; 5H/2R: VAD) consistent with involvement of these cysteine proteases in apoptotic cell death (Martin and Green, 1995) . On the other hand, carbobenzoxy-Phe-Ala-¯uoromethyl ketone, an inhibitor of non-caspase cysteine proteases, was without eect, indicating that the carbobenzoxy-and -¯uoromethyl ketone moieties were not causing nonspeci®c inhibitory eects (not shown). Reoxygenated cells protected by VAD remained morphologically normal for at least 24 h, but were not viable, since they became apoptotic within 1 h after removal of the inhibitor (not shown). The results agree with recent studies showing that caspase inhibitors retard structural deterioration, but do not confer long term viability following diverse stimuli (Xiang et al., 1996; McCarthy et al., 1997; Miller et al., 1997) . Thus, the eects of VAD could have been directed at processes that were downstream of a`point of no return' death event.
ATP levels in cells subjected to 5 h of glucose free hypoxic incubation declined steeply both in absence or presence of caspase inhibitor VAD (0.06 and 0.08 nmol ATP/mg cell protein), compared with normoxic control cells (27.8 nmol ATP/mg cell protein, see also Figure  12 ). In sharp contrast, in the presence of 5.5 mM glucose during hypoxia, the cells showed only modest declines of ATP (19.2 nmol/mg cell protein, see Figure  12 ), consistent with energy production by anaerobic glycolysis. These cells, which generated ATP during hypoxia because of the availability of glucose, were not injured and recovered fully when reoxygenated (Figure 1a ± c; 5H/2R: Glu), and proliferated subsequently (not shown). The results indicated that ATP depletion during hypoxia, rather than hypoxia per se, was required for cell death during reoxygenation.
Caspase-independent release of cyt.c during hypoxia
Since mitochondrial damage and cyt.c release have been implicated in apoptotic cell death (Liu et al., 1996; Yang et al., 1997; Kluck et al., 1997) , we assessed mitochondrial damage by examining leaked cyt.c following hypoxic incubations. To determine the subcellular distribution of cyt.c, we prepared cytosolic and membrane bound fractions. Digitonin (0.05%) was used to selectively permeabilize the plasma membranes of cells to obtain the cytosol fractions (Fiskum et al., 1980) . Digitonin insoluble residues were further extracted with Triton X-100 to release membrane associated and organelle bound proteins. Both fractions were analysed by SDS ± PAGE and Western blotting. As shown in Figure 2 , in control cells ( Figure  2a , lane 1), cyt.c was detected only in the membrane fraction (mitochondria). During glucose-free hypoxia, it was lost from this fraction and simultaneously appeared in the cytosol; the decrease was consistently evident after 3 h (Figure 2a, lane 3) . The extent of translocation increased thereafter (5H; Figure 2a , lane 4), and was complete by 7 h (not shown). When glucose was provided during hypoxia, release of mitochondrial cyt.c during hypoxic incubation was completely blocked (Figure 2a, lane 5) . Inclusion of the caspase inhibitor VAD did not prevent leak of cyt.c during hypoxia (Figure 2a , lane 6). However, during reoxygenation, provision of VAD inhibited the cyt.c mediated apoptosis suggesting that caspase activation might be occurring downstream to cyt.c release.
The immunoblotting results were con®rmed by immuno¯uorescence localization of cyt.c. As shown in Figure 2b , cyt.c was visualized exclusively in mitochondria of control cells (Figure 2b, CON) . However, after 5 h of glucose free hypoxia, approximately 50% of the cell population showed diuse cytosolic staining (Figure 2b, 5H) . Presence of glucose during hypoxia prevented cyt.c release and showed cyt.c distribution similar to control cells. After 7 h of hypoxia, mitochondrial cyt.c had been released in virtually all cells (not shown). The cyt.c that had translocated during hypoxia remained largely in the cytosol during reoxygenation (Figure 2a, lanes 4, 6, 8 and 9). To con®rm the cytosolic location of cyt.c in reoxygenated cells, we visualized its subcellular immuno¯uorescence localization by confocal microscopy of 0.7 mM optical sections (Figure 2c ). Following reoxygenation after either 3 or 5 h of hypoxia, there was diuse cytosolic staining of cyt.c in populations of cells displaying typical apoptotic morphology (Figure 2b , 5H/2R and Figure 2c , 3H/ 2R). Thus, either after a milder or more severe hypoxic duration, the subsequent development of injury correlated well with the cytosolic presence of cyt.c. VAD did not prevent the cyt.c translocation that took place during hypoxia (Figure 2a,b) , despite its inhibitory eects on caspase activation (Figure 9 , see below). Notably, cyt.c continued to remain in its cytosolic location in reoxygenated cells incubated with VAD (Figure 2a , lanes 6 and 9; Figure 2b , 5H/2R+VAD), although apoptosis was blocked completely (Figures 1 and 2b) . Thus, caspase activation is not required for cyt.c release; rather it occurs as a downstream event.
Bax translocation during hypoxia and ATP depletion
Western blot analysis revealed that RPTC express low or undetectable levels of Bcl-2, BclX L , Bid and Bad proteins (not shown). However, they express abundant Figure 1 Caspase-mediated cell death during reoxygenation. Cell death was assessed by (a) morphology, (b) DNA fragmentation and (c) nuclear lamin B breakdown. Cultured rat kidney proximal tubule cells (control, CON) were subjected to 5 h of glucose-free hypoxic incubation only (5H), or 5 h of hypoxia followed by 2 h of reoxygenation in full culture medium (5H/2R). N/A: no addition. VAD: 100 mM VAD during hypoxia and reoxygenation; Glu: 5.5 mM glucose during hypoxia. For morphological observations (a), cells were stained with Hoechst 33258 and the same ®elds of cells were photographed by phase contrast and uorescence microscopy. For analysis of DNA fragmentation (b), cells prelabeled with Bax protein as determined by immunoblotting analysis. This is consistent with the ®nding that tissues of epithelial origin express high levels of Bax (Bargou et al., 1996) . Analysis of cytosolic and membrane fractions for Bax revealed that Bax is present predominantly in the cytosol of control cells ( Figure  3a , lane 1). With increased exposure to hypoxia, Bax was lost from the cytosolic fraction and appeared in the membrane fraction ( Figure 3a , lanes 2 ± 4). Inclusion of glucose during hypoxia, to support glycolytic ATP production, inhibited Bax translocation ( Figure 3a , lane 5). On the other hand, presence of the caspase inhibitor VAD during hypoxic incubation did not prevent Bax translocation (Figure 3a , lane 6). During reoxygenation, it appeared that signi®cant amounts of Bax are relocated to the cytosol suggesting that intracellular ATP levels regulate Bax localization. These results also indicate that Bax translocation during hypoxia was related to declines of cellular ATP, and not hypoxic stress per se. To further clarify whether ATP depletion alone is the cause of Bax translocation, cells were exposed to 15 mM CCCP, a mitochondrial uncoupler, under normoxic conditions in glucose-free medium. Cells were severely ATP depleted under these conditions (not shown). As shown in Figure 3b , Bax was progressively lost from cytosol and appeared in the membrane fraction. These results con®rm that prolonged exposure to ATP depleted conditions results in Bax migration from cytosol to membrane. We also tested the eect of allowing the cells to recover in complete growth medium following ATP depletion by CCCP. After increasing periods of ATP depletion, correspondingly greater numbers of cells lost viability during recovery and became apoptotic (data not shown).
Mitochondria are the targets of Bax translocation during ATP depletion
Earlier reports have shown that apoptotic stimuli induce Bax translocation to mitochondria (Wolter et al., 1997; Gross et al., 1998) . However, those studies were done under non ATP depleting conditions. We have used confocal microscopy after double immunolabeling with antibodies against cytochrome oxidase subunit IV (COX), a mitochondrial inner membrane anchored protein, and Bax. In normal cells, COX showed typical perinuclear distribution characteristic of mitochondria (Figure 4a ), while Bax showed a diuse cytoplasmic distribution as ®ne granules (Figure 4b ). In CCCP treated cells, there was no change in COX distribution ( Figure 4c) ; however, Bax showed a dramatic redistribution to structures that were superimposable with those showing COX, indicating the presence of Bax in mitochondria ( Figure 4d ). These results provide strong evidence that Bax translocates to mitochondria during ATP depletion.
To further characterize Bax translocation to mitochondria, we expressed a recombinant Bax-green uorescent protein fusion peptide (GFP-Bax) in RPTC. In normal cells, GFP-Bax is diusely distributed in the cytosol (Figure 5a Immunoblot analysis of cytosolic and organelle-bound fractions (as described in Materials and methods) after subjecting cells to 0, 1, 3 or 5 h of hypoxia alone (lanes 1 ± 6) or hypoxia followed by reoxygenation (lanes 7 ± 9). In some groups, glucose (5.5 mM) was provided during 5 h hypoxia (Glu; lane 5), or VAD (100 mM) was included in the medium throughout the 5 h hypoxic period (VAD; lane 6) or hypoxia/reoxygenation (VAD; lane 9). The protein samples were analysed by Western blotting with anti-cyt.c 7H8.2C12, monoclonal antibody. (b) Localization of cyt.c by immuno¯uorescence. Cells were ®xed with a modi®ed Zamboni's ®xative, processed for cyt.c immuno¯uorescence as described in Materials and methods, and examined by conventional¯uorescence microscopy. CON: control cells without hypoxia; 5H: 5 h of hypoxia; 5H/2R: 5 h of hypoxia followed by 2 h of reoxygenation; 5H/2R+VAD: 100 mM VAD was provided during 5 h of hypoxia and 2 h of reoxygenation. (c) Confocal microscopy. After immunostaining of cyt.c, cells were examined by confocal microscopy of 0.7 mm optical sections. 3H/2R: 3 h of hypoxia followed by 2 h of reoxygenation. Shown in the inset is an apoptotic cell with negative images of nuclear fragments surrounded by diuse cytosolic cyt.c tion to mitochondria. After reoxygenation, cells harboring mitochondrial GFP-Bax underwent apoptotic morphological changes (Figure 5c ).
Cyt.c is released in cells harboring Bax in mitochondria
Bax translocation to mitochondria and release of cyt.c from mitochondria are seen in parallel ( Figure 6a ). Both translocations are inhibited by glucose ( Figure 6a , lanes 5 and 11) but are not altered by VAD (Figure 6a , lanes 6 and 12). This observation raised the possibility that Bax may be involved in the release of cyt.c by altering mitochondrial outer membrane permeability. However, immunoblot analysis cannot rule out the possibility that both translocations can be occurring in parallel but independent of each other. We resolved this by visualizing cells by indirect immuno¯uorescence after double labeling for both Bax and cyt.c. If the two processes occurred independently of each other, we expected to detect cells in which cyt.c might be released without Bax translocation and vice versa. Bax, which is diusely present as ®ne granules in the cytosol of controls (Figure 6b , panel A) translocated to mitochondria during hypoxia with a punctate perinuclear distribution typical of mitochondria (Figure 6b , panel C). In contrast, cyt.c, which is localized to the large perinuclear mitochondria in controls (Figure 6b 
Overexpression of Bcl-2 blocks cyt.c translocation during hypoxia and apoptosis during reoxygenation without inhibiting Bax translocation
It has been shown that overexpression of Bcl-2 blocks cyt.c release from mitochondria in response to a variety of apoptotic stimuli (Yang et al., 1997; Kluck et al., 1997) . To further de®ne the potential role of Bax in the development of hypoxic injury, we overexpressed Bcl-2 in these kidney cells. The expression of Bcl-2, an antiapoptotic protein (Yang and Korsmeyer, 1996) , is low to non-detectable in cultured kidney proximal tubule cells (Figure 7a , lane 1). Stable transfection of these cells with a vector containing a cDNA encoding Bcl-2 led to overexpression of this protein several fold over the wild type (Figure 7a , lanes 2 and 3) or control vector transfected cells (not shown) as veri®ed by Western blot analysis. By immuno¯uorescence, Bcl-2 was found only in mitochondria of wild-type cells, but in overexpressing cells, Bcl-2 distribution included mitochondria as well as other organelles (not shown).
Bcl-2 overexpressing cells (Bcl-2 1 ) did not show either apoptotic morphology or DNA fragmentation (data not shown) during reoxygenation after hypoxia. Bcl-2 expressing cells also did not leak mitochondrial cyt.c during hypoxia (Figure 7d and f) or reoxygenation (not shown). Moreover, proteolytic cleavage of lamin B during reoxygenation was also blocked by Bcl-2 ( Figure   Figure 3 Membrane translocation of Bax. Immunoblot analysis of Bax in cytosolic and membrane fractions. (a) Cells were subjected to 0, 1, 3, or 5 h of hypoxia (lanes 1 ± 6) or hypoxia followed by 2 h reoxygenation (lanes 7 ± 9). Some groups were made hypoxic for 5 h in the presence of 5.5 mM glucose (lane 5). Or 100 mM VAD (lane 6). For lane 9, VAD (100 mM) was provided throughout hypoxia and reoxygenation. Cell extracts were prepared and separated as described in Materials and methods. The blots were probed with monoclonal anti-Bax antibody (1D1). (b) Cells were exposed to 15 mM CCCP, a mitochondrial uncoupler, under normoxic conditions in glucose free medium. Prolonged exposure to CCCP (0, 1, 2, 3 h; lanes 1 ± 4) resulted in loss of Bax from cytosol (lanes 1 ± 4) and appearance of Bax in the membranes (lanes 5 ± 8) Heterodimerization of Bax and Bcl-2 in mitochondria is not the mechanism of Bcl-2 protection
We tested the hypothesis that formation of Bax/Bcl-2 heterodimers in the mitochondrial membranes may be the cause of Bcl-2 protection. In the absence of detergent, Bax antibody (P-19) failed to immunoprecipitate Bax from soluble cytosolic extracts (Figure 8 , lane 1) indicating that the N-terminal epitope of Bax (amino acids 43 ± 61), which contains the binding site for the P-19 antibody, is not exposed in cytosolic Bax.. However, in the presence of detergent, P-19 antibody strongly binds to Bax (Figure 8, lane 2) showing that this reagent can be reliably used for immunoprecipitation studies in the presence of detergent. Similar masking and unmasking of epitope in the N-terminus of Bax in the absence or presence of detergents has been reported earlier (Hsu and Youle, 1998) . Immunoprecipitation of Bax from membrane fractions of control and ATP depleted cells after detergent solubilization did not co-precipitate Bcl-2 (Figure 8 , lanes 3 and 5) suggesting that either P-19 antibody does not recognize Bax/Bcl-2 heterodimers or that there were no heterodimers in the membrane. On the other hand, anti-Bcl-2 antibody (CD-21), precipitated predominantly Bcl-2 but failed to co-precipitate the vast majority of membrane bound Bax, only very small amounts of Bax being apparently in association with Bcl-2 (Figure 8, lanes 4 and 6) . This suggested that CD-21 antibody can recognize Bax-Bcl-2 heterodimers and that only a very minor fraction of mitochondrially translocated Bax exists in this form. Formation of BaxBcl-2 heterodimers may even be an artefact of detergent solubilization. Taken together, these results suggest that only a small fraction of Bax, if at all, in the mitochondrial membrane may form heterodimers with Bcl-2. Since both homodimerization and heterodimerization of Bax were shown earlier to be detergent induced processes (Hsu and Youle, 1998) , it is likely that Bax is inserted into mitochondrial membrane as a monomer or more probably as a homodimer during hypoxia.
Activation of caspases during hypoxia and reoxygenation
Earlier reports have suggested that activation of caspases occurs during ischemia (Kaushal et al., 1998) . To delineate the role of caspases in hypoxic injury, we measured caspase activity in cells that were subjected to hypoxia. We examined caspase activities using the cleavage of tetrapeptides speci®c for various caspase species. As shown in Figure 9 , DEVDase (caspase-3) activity progressively increased over 30-fold following hypoxic incubation in parallel with the cyt.c release that was observed (see Figure 2a) . Other caspases showed similar stimulation during hypoxia, but of much smaller magnitude: IETDase (caspase-8; Figure 9 ), LEHDase (caspase-9, to the same extent as IETDase activity; not shown), and VDVADase (caspase-2; to the same extent as IETDase; not shown). Other caspases (caspase-1, -4, -5, -6, -7 and -10) did not show signi®cant stimulation (data not shown). Increase in DEVDase activity throughout the hypoxic duration was completely inhibited by VAD (not shown). Stimulation of DEVDase activity during hypoxia was markedly suppressed by inclusion of glucose which raised ATP levels, and by the Bcl-2 phenotype despite severe ATP depletion (Figure 9 ). During reoxygenation, DEVDase activity was further stimulated but only marginally (not shown). We also observed proteolytic breakdown of caspase-3 by immunoblot analysis (not shown) indicating that DEVDase activity is related to caspase-3 activation. Although caspase-3 had already been activated to near maximal levels during hypoxia, it failed to induce biochemical or morphological changes characteristic of apoptosis during the hypoxic period. These apoptotic changes required ATP generation during reoxygenation. This suggests that ATP generated during reoxygenation is required for the ampli®cation events and migration of caspases into nuclei or other subcellular sites to induce morphological changes.
Reoxygenation in glucose-free medium results in caspase-independent and Bcl-2 inhibitable necrotic cell death Cells injured by ischemia/reperfusion can display necrotic as well as apoptotic morphology (Kato et al., 1997; Kajstura et al., 1998; Li et al., 1998a; Wiegele et al., 1998; Lieberthal and Levine, 1996) . Apoptosis is an energy dependent process (Wyllie, 1994; Vaux and Strasser, 1996) . Consequently, if glycolysis is also compromised in cells with damaged mitochondria, cell death by caspase-independent mechanisms might be expected to prevail. We surmised that Bax induced cyt.c translocation could be the common lethal`single hit' underlying either form of cell death in the model we are studying, since it can result in two dierent, but equally serious cellular defects: impaired electron transport, and activation of caspases. Impaired electron transport Figure 6 Cyt.c is released into the cytosol only in cells harboring mitochondrial Bax. (a) Immunoblot analysis of Bax and cyt.c in cells subjected to hypoxia. Cytosolic (lanes 1 ± 6) and membrane (lanes 7 ± 12) fractions were analysed by Western blot analysis for both Bax and cyt.c as described in Materials and methods. Prolonged exposure to hypoxia resulted in the loss of Bax from the cytosol (lanes 3 and 4) with concomitant increase of Bax in mitochondria (lanes 9 and 10). Concomitantly, cyt.c appeared in the cytosol (lanes 3 and 4) and decreased in mitochondria (lanes 9 and 10). Glucose (Glu; lanes 5 and 11) inhibited redistribution of both Bax and cyt.c. Caspase inhibitor VAD has no eect on hypoxia induced protein translocations (VAD; lanes 6 and 12). due to loss of mitochondrial cyt.c would prevent recovery of cellular ATP pools if anaerobic glycolysis is not feasible, and thus lead to death by caspaseindependent processes due to prolonged ATP depletion. On the other hand, apoptosis will result if energy levels increase by virtue of glycolysis, since the suicide cascade of caspases is activated by cytosolic cyt.c in the presence of ATP Zou et al., 1997) . We investigated these contingencies by selectively omitting glucose from the reoxygenation medium. Incubation of previously (Figure 10 ). The enhanced Hoechst 33258 staining in these cells could be a consequence of plasma membrane permeabilization and greater access of nuclear DNA to the dye. This was suggested by similarly increased Hoechst 33258 staining of nuclei in cells rapidly lysed with detergents (not shown). Cell death by necrosis during reoxygenation in glucose-free medium was not suppressed by 100 mM VAD ( Figure  10 ; electron microscopy not shown), suggesting a caspase-independent process. Importantly, overexpression of Bcl-2 completely blocked this form of cell death as well (Figures 10 and 11d) . Thus, reoxygenation-associated cell death can be prevented by Bcl-2, regardless of whether the death mechanisms are mediated by caspases or not.
Bcl-2 preserves mitochondrial integrity and promotes ATP generation in the absence of glucose during reoxygenation During hypoxic incubation, ATP production by oxidative phosphorylation is inhibited due to lack of the terminal electron acceptor, oxygen. Under these conditions, cell ATP should decrease rapidly if glycolysis is prevented by metabolic substrate deprivation. Steep declines of ATP were revealed in cells after 5 h of hypoxic incubation without glucose (Figure 12b , 5H: N/A). Inclusion of glucose during hypoxia maintained ATP at substantial levels ( Figure 12b , 5H: Glu) and prevented both protein translocations and cell death (Figures 1, 2 and 3) . VAD did not ameliorate ATP declines during hypoxia (Figure 12b , 5H: VAD). Upon reoxygenation, ATP production in cells with translocated cyt.c was dependent on glycolysis. Thus, little ATP was detected when hypoxic cells were reoxygenated in glucose-free medium ( Figure  12b ; 1r), while substantial ATP was generated in the presence of glucose (Figure 12b: 1R) .
Cellular energy levels during hypoxia were not modi®ed by Bcl-2. Decreases of ATP were equally severe in hypoxic cells of the wild-type and Bcl-2 phenotype ( Figure 12b , 5H: N/A and Figure 12c, 5H) . However, reoxygenation of hypoxic cells of the Bcl-2 phenotype resulted in regeneration of ATP (Figure 12c : 1R), even in the absence of glucose (Figure 12c: 1r) . By inference, this indicated that the degree of mitochondrial integrity required for respiratory function and oxidative phosphorylation had been preserved during hypoxia in these cells by Bcl-2 and that inhibition of cyt.c translocation had been responsible for the protective eects. Based on the results presented so far, we propose a general scheme for the evolution of cell death in this model of hypoxia and reoxygenation injury (Figure 13 ). 
Discussion
Members of Bcl-2 family, including the pro-apoptotic Bax, form pH-sensitive, ion-conducting channels in planar lipid bilayers in vitro, implicating membrane permeabilizing eects of these proteins (Minn et al., 1997; Schendel et al., 1997; Antonsson et al., 1997) . Bax is thought to be present in the cytosol in a monomeric form since enforced dimerization leads to its mitochondrial translocation (Gross et al., 1998) . Although the mechanisms that are responsible for retaining Bax in the cytosol are under continuing investigation, it is likely that monomeric Bax may be tethered to a cytosolic chaperone protein under normal conditions. Previous studies have indicated that Bax undergoes conformational changes in response to death signals from cytotoxic insults such as staurosporine or survival factor withdrawal resulting in Bax homodimerization and mitochondrial membrane insertion (Wolter et al., 1997; Gross et al., 1998) . However, these death signals are not mediated by ATP depletion. Decreases of cell ATP occur relatively late in other forms of apoptosis (Bossy-Wetzel et al., 1998) ; thus, it is unlikely that ATP depletion is a primary mechanism required for the initiation of death pathways in these models. Nevertheless, our observations using the hypoxia model may ultimately yield clues regarding the molecular processes that underlie Bax translocation. Since ATP depletion shifts the equilibrium to dephosphorylation, it is conceivable that phosphorylation/dephosphorylation mechanisms may in¯uence Bax localization by in¯uencing its interactions with a putative chaperone. This possibility deserves further investigation.
Cyt.c, the soluble mitochondrial electron carrier, is located in the intermembrane space and will diuse outwards and migrate to the cytosol if outer mitochondrial membranes become permeable or damaged. Loss of mitochondrial cyt.c has been detected during in vivo ischemia and hypoxic perfusion of hearts, which was associated with loss of mitochondrial respiration and followed by augmented cell injury after reoxygenation (Piper et al., 1985; Naro et al., 1993; Borutaite et al., 1996) . Addition of exogenous cyt.c to mitochondria isolated from ischemic hearts corrected the respiratory defect (Piper et al., 1985; Borutaite et al., 1996) . Several considerations indicate that translocation of cyt.c will be fatal to the aected cell. Firstly, being an integral component of the electron transport chain, loss of cyt.c would assure the cessation of respiration and oxidative phosphorylation, without which mammalian cells cannot survive even if glycolysis is not limiting. Secondly, if glycolytic metabolism is compromised, the ensuing failure to recoup cellular energy stores would be certain to result in cell death due to lack of ATP. Thirdly, cyt.c leaked into the cytosol has been identi®ed as a possiblè trigger' which activates the apoptotic cascade of Figure 10 Caspase-independent cell death during reoxygenation in glucose free medium and its inhibition by Bcl-2. Wild-type cells and Bcl-2 overexpressing cells were subjected to 5 h of hypoxia, and then reoxygenated for 1 h in glucose-free culture medium. N/A: no addition. VAD: 100 mM VAD was provided during hypoxia/reoxygenation. Bcl-2: hypoxia/reoxygenation was done on Bcl-2 overexpressing cells. After reoxygenation, cells were exposed to PBS containing 2 mg/ml propidium iodide (PI) and 8 mg/ml Hoechst 33258 (Hoechst). Cell morphology, PI staining and Hoechst staining of the same ®eld of cells were recorded caspases in conjunction with an ATP-bound cytosolic co-factor, Apaf-1 . Directly relevant to these considerations is our observation that VAD fully suppressed the apoptotic death cascade and maintained cell structure during reoxygenation, but only in the continued presence of the caspase inhibitor. Death ensued rapidly when the inhibitor was removed (unpublished results).
Identi®cation of mitochondrial targets for Bax and its inhibitor Bcl-2 is crucial to the understanding of the mechanisms leading to cyt.c release after Bax translocation. Our data (Figure 8 ) indicate that the major fraction of mitochondrially translocated Bax in Bcl-2 overexpressing cells does not exist in the form of Bax/Bcl-2 heterodimers. Our results (Figure 8) show that such heterodimers are a very small minority at best. Therefore, Bcl-2 cytoprotective eects are not likely to be due to formation of inactive Bax-Bcl-2 heterodimers. These cytoprotective actions may be explained by invoking a mitochondrial membrane protein or proteins which can form hetero-multimers with Bax and Bcl-2. In the absence of Bcl-2, translocated Bax may form protein-translocating pores in the outer membrane. If Bcl-2 is overexpressed, it may compete with Bax to inhibit such a channel formation without inhibiting Bax translocation. A recent report supporting this hypothesis has shown that Bax may interact with adenine nucleotide translocator protein in the mitochondria to induce permeability changes across mitochondrial membrane (Marzo et al., 1998) .
Alternatively, instead of forming protein-translocating pores, Bax may induce mitochondrial swelling during hypoxia thus causing rupture of outer membranes and release of cyt.c. Disruption of mitochondrial transmembrane potential has been implicated in some apoptotic models and a central coordinating role has been proposed for mitochondrial permeability transition (MPT) in this form of cell death (Kroemer et al., 1997) . MPT has been reported to occur during in vitro hypoxia/reoxygenation and in vivo ischemia/reperfusion, and moreover, inhibitors of MPT such as cyclosporin A protect cells against injury under these conditions (Pastorino et al., 1993; Griths and Halestrap, 1995; Folbergrova et al., 1997; Qian et al., 1997) . Thus, the MPT might be involved in determining the leakage of cyt.c. However, there is experimental evidence against this hypothesis (Yang et al., 1997; Kluck et al., 1997; Bossy-Wetzel et al., 1998) , and how the MPT may be related to cyt.c leakage remains uncertain.
It has been reported earlier that caspase proteases are involved in hypoxic or ischemic cell death (Shimizu et al., 1996; Cheng et al., 1998; Yaoita et al., 1998; Kaushal et al., 1998) . Our results indicated that during hypoxia, DEVDase activity (caspase-3, a distal eector caspase) is increased more dramatically than other proximal protease activities such as caspase-8 (IETDase) or -9 (LEHDase). During hypoxia or ATP depletion, caspase-3 is activated in a time-dependent manner similar to Bax and cyt.c translocations ( Figure  9 ). However, Caspase-3 activation is not required for Bax translocation and cyt.c release, since both these mitochondrial processes are not inhibited by caspase inhibitors (Figures 2 and 3) . Previously it was shown that translocation of Bid, another Bcl-2 family death agonist, absolutely requires caspase-8 activation (Luo et al., 1998; Li et al., 1998b) . However, Bid induced mitochondrial damage is secondary to primary damage caused by caspases in receptor-mediated cell death pathways. In our hypoxic model, caspase activation is downstream to mitochondrial damage induced by Bax. Despite caspase-3 activation during hypoxia, morphological alterations resembling apoptosis did not occur suggesting that ATP is absolutely required to trigger the downstream biochemical and morphological changes of apoptosis. The events that require ATF probably involve translocation of active caspase-3 to the cellular targets such as nuclei and other cytoplasmic structures.
The immediate proximate cause of caspase-3 activation during hypoxia or ATP depletion is unclear. Three mutually non-exclusive possibilities could account for the activation of caspase-3. First, released cyt.c, in conjunction with cytosolic factors like apaf-1 and caspase-9, may stimulate the conversion of pro-caspase-3 to active protease in presence of dATP/ ATP (Thornberry and Lazebnik, 1998) . Whether sucient dATP is still available during ATP depletion is not known. Second, it has been reported that a novel apoptosis inducing factor (AIF) is released from mitochondria by agents that induce mitochondrial permeability transition (MPT; Kroemer et al., 1997; Susin et al., 1996) . AIF is released as a result of permeability transition (PT) pore opening, and may directly activate caspase-3. However, the nature of AIF is not known, and its role in our model cannot be speculated upon. Third, another likely explanation for increased DEVDase activity during hypoxia could be the release of mitochondria-associated caspase-3 during hypoxia. Recently, a caspase-3 precursor was identi®ed to be present both in mitochondria and the cytosol (Mancini et al., 1998) . Although the precursor was lost ; after 5 h of hypoxia followed by 1 h of reoxygenation in full culture medium containing 17.5 mM glucose (lane 2: 2R), or 5 h of hypoxia followed by 1 h of reoxygenation in glucose-free medium (lane 3: 2R). Cell proteins were analysed for lamin B by immunoblotting as described in Materials and methods. Cell ATP levels in wild-type cells (b) and Bcl-2 overexpressing cells (c) which were subjected to hypoxia or hypoxia/reoxygenation. CON: control without hypoxia exposure. 5H: 5 h of hypoxia. 1R: 1 h of reoxygenation in full culture medium containing 17.5 mM glucose after 5 h of hypoxia. 1r: 1 h of reoxygenation in glucose-free medium after 5 h of hypoxia. In some groups, 5.5 mM glucose (Glu), 100 mM VAD (VAD) or no agents (N/A) were provided during hypoxia. Cell ATP was extracted with trichloroacetic acid and analysed by luminometry of the luciferin-®re¯y luciferase reaction. Values are means+s.e.m. (n=4) Figure 13 Scheme for evolution of cell injury by hypoxia/ reoxygenation from the mitochondria following apoptotic stimulation it was not determined whether the precursor was activated in mitochondria and then released into the cytosol, or whether it was activated after release. Bcl-2 regulation is common to all these three possible pathways of caspase-3 activation during hypoxia. Therefore, more studies are warranted to more precisely identify the mechanisms that may be responsible for the increased DEVDase activity (activation of caspase-3) during hypoxia.
The studies in this paper point to a critical role of Bcl-2 family proteins in mitochondria in the induction and regulation of hypoxia/reoxygenation mediated cell death of cultured proximal tubule cells. The data reported here also provide new clues about events that may trigger apoptotic and necrotic cell death pathways in this form of cell death. Although our present studies point to critical role played by Bax translocation during hypoxia-reoxygenation injury in cultured renal tubular cells, further investigation is required to determine whether similar death paradigms operate during ischemic injury of the kidney or other organs in vivo. Injury mechanisms such as irreparable damage to the respiratory chain or mitochondrial permeability transitions could also lead to cell death in the context of hypoxia-reoxygenation without need to invoke Bax cytotoxicity. The role played by mitochondrial events and more downstream, caspase related and caspaseindependent death pathways deserves study in other models of hypoxic and ischemic injury. 1 KH 2 PO 4 , 4 KCl, 1 MgSO 4 , 1.25 CaCl 2 and 27 NaHCO 3 ) at 378C. The incubation medium was pregassed with 95% N 2 /5% CO 2 . EC Oxyrase, a biocatalytic oxygen reducing agent, was added at 1.2 units/ml to the medium to consume residual O2 and maximize the degree of hypoxia (Weinberg et al., 1997) . Glycine was included at 5 mM in the medium to simulate glycine contents of tissues in vivo (Nissim and Weinberg, 1996; Duran et al., 1990) , and thus prevent early necrotic injury during hypoxic incubation (Venkatachalam and Weinberg, 1993) . After hypoxia, cells were transferred back to culture medium in 95% air/5% CO 2 for reoxygenation.
ATP depletion by carbonyl cyanide-m-chlorophenylhydrazone (CCCP)
RPTC were subjected to ATP depletion after washing cells grown overnight in PBS and incubating them with glucosefree KRB containing 15 mM CCCP at 378C under normoxic conditions. After incubation, cells returned to normal growth medium to monitor eects of ATP depletion.
Detection of cell death
Cells were examined by phase contrast and¯uorescence microscopy after intravital staining with Hoechst 33258 and propidium iodide (Simm et al., 1997) . In addition, they were ®xed in 2% glutaraldehyde followed by 1% Osmium tetroxide, and processed for electron microscopy (Dong et al., 1998) . Cell death was quantitated by measuring the fragmentation of 3 H-thymidine labeled DNA (Duke et al., 1983) . Nuclear lamin B was detected by immunoblotting as described (Dong et al., 1998) . Brie¯y, cells were scraped and pelleted in the presence of protease inhibitors (2 mM phenylmethylsulfonyl¯uoride, 1 mg/ml pepstatin, 1 mg/ml leupeptin and 20 mg/ml antipain). Cell pellets were then dissolved in sample buer (6 M urea, 2% SDS, 5% bmercaptoethanol and 62.5 mM Tris; pH 6.8). Proteins in the whole-cell lysates were resolved by SDS ± PAGE, electroblotted onto PVDF membranes and probed with a polyclonal anti-lamin B antibody.
Immunoanalysis
For immunoblotting, cytosolic and mitochondrial fractions were prepared by selective plasma membrane permeabilization with digitonin (Fiskum et al., 1980) . After treatment with 0.05% digitonin in isotonic sucrose buer (composition in mM: 250 sucrose, 10 HEPES, 10 KCl, 1.5 MgCl 2 , 1 EDTA and 1 EGTA; pH 7.1), for 1 min at room temperature, soluble fractions of permeabilized cells containing cytosol were saved. Insoluble fractions were further extracted with ice-cold 0.5% Triton X-100 in isotonic sucrose buer for 10 min to release membrane and organelle bound soluble proteins including mitochondrial cyt.c. Protease inhibitors were included in all solubilization buers. Cellular fractions sequentially solubilized by digitonin and Triton X-100 were centrifuged at 15 000 g for 10 min at 48C. Proteins in the resultant supernatants were resolved by SDS ± PAGE and electroblotted onto PVDF membranes for Western blot analysis using appropriate antibodies. For immuno¯uorescence, cells were ®xed with a modi®ed Zamboni's ®xative (4% paraformaldehyde and 0.19% picric acid in PBS, pH 7.4) for 1 h at room temperature. Fixed cells were permeabilized with 0.1% SDS at RT for 5 min, blocked with serum, and exposed to a primary antibody followed by CY3-conjugated secondary antibodies (Jackson ImmunoResearch, West Grove, PA, USA). For double immunolabeling, cells were exposed simultaneously to two primary antibodies, a-Bax (rabbit polyclonal, Pharmingen, CA, USA) and a-cyt.c (monoclonal, Clone 2G8.B6) followed by FITC-conjugated anti-mouse and CY3-conjugated antirabbit antibodies (Jackson ImmunoResearch).
Bcl-2 overexpression
Cells were co-transfected with a Bcl-2 expression vector (pbactBcl-2) and a hygromycin B resistance selectable expression vector by using SuperFect transfection reagent. After hygromycin (400 mg/ml) selection, resistant clones were subcultured. Overexpression of Bcl-2 in these clones was con®rmed by immunoblotting.
Caspase assay
Following experimental incubation, cells were lysed in 1% Triton X-100 in 25 mM HEPES, 115 mM NaCl, 1 mM KH 2 PO 4 , 4 mM KCl buer (pH 7.4). To measure caspase activity, 50 mg of lysates were added to reaction mixtures containing 50 mM peptide substrate (DEVD-AFC, IETD-AFC etc.), 100 mM HEPES, 10% sucrose, 0.1% CHAPS, 1 mM EDTA, and 10 mM DTT pH 7.4 in a total volume of 200 ml and incubated at 378C for 1 h. Production of AFC was monitored in an SpectroFluor plate reader (Tecan US Inc., Research Triangle Park, NC, USA) using excitation wavelength 360 nm and emission wavelength 530 nm.
Cloning and expression of GFP-Bax
Rat bax cDNA was isolated by RT ± PCR from rat proximal tubule cells by using primers 5'-GGA ATT CAT GGA CGG GTC CGG GGA and 5'-GGA ATT CTC AGC CCA TCT TCT TCC AG. A *600 bp PCR product containing the entire coding sequence of Bax was cloned. For GFP-fusion constructs, a 5' primer containing HindIII restriction enzyme site in place of start codon was used to further amplify bax cDNA. The PCR product was digested and subcloned in the C3-EGFP plasmid (Clontech Laboratories Inc., Palo Alto, CA, USA) between HindIII and EcoRI sites. RPTC were plated at 2.5610 5 cells/ coverslip in a 35 mm culture dish 1 day before transfection. Cells were transiently transfected with 1 mg of GFP-Bax fusion vector DNA using Lipofectamine plus (GIBCO-BRL, Gaithersburg, MD, USA) in serum containing medium overnight as described by the manufacturer. One day after transfection, the cells were washed and subjected to hypoxia or ATP depletion as described above. Cells were visualized for intravital microscopy by placing the cell sides of coverslips over aliquots of incubation buer on glass slides.
Chemical analyses
Cell protein was quantitated with the bicinchoninic acid (BCA) reagent (Pierce Chemical Company, Rockford, IL, USA). To measure ATP, cells were extracted with trichloroacetic acid. After removal of the acid with Freon-trioctylamine, ATP was measured by luminometry of the luciferin-®re¯y luciferase reaction (Garza-Quintero et al., 1990) .
